Business · 02/04/2018
FDA Denies Hearing Requests for Polyethylene Glycol 3350 Prescription Laxatives
The FDA Commissioner is withdrawing approval of abbreviated new drug applications for certain prescription laxatives containing polyethylene glycol 3350 due to misbranding under the FD&C Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →